找不到产品?留下需求帮您找
一键询价UPCISCC090 人舌头鳞癌细胞 QCH766
7天
3500¥
KNS62 人肺支气管鳞状细胞癌 QCH767
7天
3500¥
HCC95 人肺腺癌细胞 QCH768
7天
3500¥
HARA 人肺腺癌细胞 QCH769
7天
3500¥
EPLC272H 人肺腺癌细胞 QCH770
7天
4000¥
NCI-H810 人非小细胞肺癌细胞 QCH771
7天
5000¥
HBL-1 人弥漫性大B细胞淋巴瘤 QCH772
7天
1800¥
FTC238 人滤泡状甲状腺癌细胞,肺转移 XY-H773
7天
3500¥
SNU-719 人胃癌细胞 QCH774
7天
3500¥
BT549+GFP+LUC 人乳腺癌细胞 QCH766GL
钦诚生物 | 一周
4500¥
公告提醒:爱必信所有产品和服务仅用于科学研究,不用于临床应用及其他用途提供产品和服务(也不为任何个人提供产品和服务)!
抑制剂描述: 产品名称:Enasidenib mesylate 产品别名:见爱必信官网 英文别名:Enasidenib mesylate 靶点:IDH CAS:1650550-25-6 纯度:98% 外观:见爱必信官网 保存方法:store at -20℃ for one year(Powder) 描述:Enasidenib mesylate is a first-in-class, oral, potent, reversible, selective inhibitor of the IDH2 mutant enzymes. 溶解性: 体外研究: Enasidenib (AG-221) reverses the effects of mutant IDH2 on DNA methylation in mutant stem/progenitor cells. Enasidenib induces differentiation and impairs self-renewal of IDH2-mutant leukemia cells, effects that are further enhanced by simultaneous inhibition of Flt3ITD. Enasidenib (AG-221) therapy induces differentiation of leukemic cells, with an increase in the CD11b+ population and a decrease in the c-Kit+ population in the peripheral blood at 2 wks. 体内研究:Enasidenib (AG-221) reverses the effects of mutant IDH2 on DNA methylation in mutant stem/progenitor cells. Enasidenib induces differentiation and impairs self-renewal of IDH2-mutant leukemia cells, effects that are further enhanced by simultaneous inhibition of Flt3ITD. Enasidenib (AG-221) therapy induces differentiation of leukemic cells, with an increase in the CD11b+ population and a decrease in the c-Kit+ population in the peripheral blood at 2 wks.
产品信息订购:
|
Enasidenib mesylate多少钱?
爱必信生物分子的应用资料有吗?
爱必信生物分子货号abs821096报价含票含运吗?
爱必信货号abs821096货期是多久?
爱必信Enasidenib mesylate可以申请试用吗?
爱必信爱必信生物分子售后政策是什么?
Enasidenib mesylate有现货吗?